Dare Bioscience Quote - DARE

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.34

Bid

3.30

Ask

3.41

Volume

30,183

3.18 Day's Range 3.42

3.05 52 Week Range 7.56

Market Cap

29.059M

Previous Close

3.23

Open

3.23

Last Trade

3.3

Last Trade Time

Financial Volume

US$ 100,181

VWAP

3.3191

Average Volume (3m)

42,338

Shares Outstanding

8,700,389

Dividend Yield

PE Ratio

-0.96

Earnings Per Share (EPS)

-3.47

Revenue

2.81M

Net Profit

-30.16M

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve... Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.darebioscience.com

Headquarters

Wilmington, Delaware, USA

Founded

Dare Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DARE. The last closing price for Dare Bioscience was US$3.23. Over the last year, Dare Bioscience shares have traded in a share price range of US$ 3.05 to US$ 7.56.

Dare Bioscience currently has 8,700,389 shares outstanding. The market capitalization of Dare Bioscience is US$28.10 million. Dare Bioscience has a price to earnings ratio (PE ratio) of -0.96.

Form D - Notice of Exempt Offering of Securities

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update

Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate – pivotal Phase 3...

Daré Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene® Pivotal Study Clinical Trial Sites

- Grant funds will support activities that will aid in the identification and development of a novel non-hormonal intravaginal contraceptive product candidate. - Grant will also provide funding...

Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024

SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, will host a conference call and live webcast at...

Form 8-K - Current report

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

DARE-HPV is a potential first-in-category treatment for human papillomavirus (HPV)-related cervical disease which could change the treatment paradigm for clinical HPV management. Essentially all...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.17	-4.8433048433	3.51	3.585	3.18	51109	3.20578418	CS
4	-0.17	-4.8433048433	3.51	4.6	3.18	60580	3.80481704	CS
12	-0.23	-6.44257703081	3.57	4.6	3.18	42338	3.60252465	CS
26	-1.592	-32.2789943228	4.932	6.24	3.05	123023	4.64373682	CS
52	-0.7256	-17.8473042109	4.0656	7.56	3.05	394061	4.42702491	CS
156	-17.06	-83.6274509804	20.4	30.12	3.05	910424	17.51239995	CS
260	-6.26	-65.2083333333	9.6	46.2	3.05	1485267	19.7494669	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	425.38M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	236.51M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	159.61M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	159.39M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	107.91M